Vigil Neuroscience, Inc.
VIGL
$1.67
-$0.10-5.65%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.63% | -0.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.46% | -8.02% | |||
| Operating Income | -21.46% | 8.02% | |||
| Income Before Tax | -23.75% | 9.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -23.75% | 9.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -23.75% | 9.28% | |||
| EBIT | -21.46% | 8.02% | |||
| EBITDA | -21.59% | 8.06% | |||
| EPS Basic | -20.52% | 9.31% | |||
| Normalized Basic EPS | -20.60% | 9.32% | |||
| EPS Diluted | -20.52% | 9.31% | |||
| Normalized Diluted EPS | -20.60% | 9.32% | |||
| Average Basic Shares Outstanding | 2.68% | 0.03% | |||
| Average Diluted Shares Outstanding | 2.68% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
